Which laboratory tests should be obtained to evaluate a patient with suspected liver cirrhosis?

Laboratory Evaluation for Suspected Liver Cirrhosis

Order a comprehensive hepatic function panel including complete blood count with platelets, comprehensive metabolic panel with liver enzymes (AST, ALT, alkaline phosphatase, GGT), albumin, total and direct bilirubin, PT/INR, and creatinine to assess synthetic function, portal hypertension severity, and prognosis. 1

Core Laboratory Panel

The initial workup requires a systematic approach to evaluate both hepatocellular function and complications of portal hypertension:

Essential Tests for Diagnosis and Severity Assessment

• Complete Blood Count (CBC): Platelet count is critical—thrombocytopenia (platelet count <160 × 10³/μL) strongly suggests portal hypertension and likely cirrhosis with a likelihood ratio of 6.3 1, 2. A platelet count ≥160 × 10³/μL substantially lowers the likelihood of cirrhosis (LR 0.29) 2.

• Comprehensive Metabolic Panel: Must include AST, ALT, alkaline phosphatase, total and direct bilirubin, albumin, and creatinine 1. Bilirubin is considered the best single test of overall liver function 3.

• Liver Enzymes Pattern Recognition:

  • AST and ALT typically do not exceed 400 IU/mL in cirrhosis; higher values suggest alternative diagnoses like drug-induced injury 1
  • An AST/ALT ratio >2 is highly suggestive of alcoholic liver disease, with ratios >3 being even more specific 1
  • GGT is essential for detecting hepatobiliary involvement and calculating fibrosis indices 1

• Synthetic Function Markers:

  • PT/INR is critical for assessing hepatic synthetic capacity and is required for Child-Pugh and MELD scoring 1
  • Hypoalbuminemia (albumin <3.5 g/dL) indicates decreased synthetic function and advanced disease, with >95% specificity for cirrhosis 1, 4
  • An INR >1.3 has >95% specificity for identifying cirrhosis 4

Prognostic Scoring Systems

Calculate these scores using the laboratory values obtained:

• MELD-Na Score: Uses bilirubin, INR, creatinine, and sodium to predict mortality (scores range 6-40) 1

• Child-Pugh Score: Incorporates albumin, bilirubin, INR, plus clinical parameters (ascites, encephalopathy) to assess cirrhosis severity 1

• FIB-4 Index: Uses age, AST, ALT, and platelet count to estimate fibrosis stage 1

• Lok Index: A score <0.2 (derived from platelet count, AST, ALT, and INR) has the strongest ability to exclude cirrhosis (LR 0.09) 2

• Bonacini Cirrhosis Discriminant Score: A score >7 strongly suggests cirrhosis (LR 9.4) 2

Additional Diagnostic Considerations

When Specific Etiologies Are Suspected

If the initial panel suggests cirrhosis, order a comprehensive liver etiology screen including 5:

• Hepatitis B surface antigen and hepatitis C antibody
• Autoimmune markers: anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins
• Metabolic screening: ferritin and transferrin saturation (for hemochromatosis)
• For patients under 25 years: alpha-1-antitrypsin level, ceruloplasmin (for Wilson disease) 5

Screening for Complications

• Ascites Evaluation: If ascites is present, perform diagnostic paracentesis immediately and calculate the serum-ascites albumin gradient (SAAG) to confirm portal hypertension 1

• Hepatocellular Carcinoma Screening: Patients with confirmed cirrhosis require ultrasound screening every 6 months, as HCC incidence ranges from 7-16% at 5 years 1

Monitoring Schedule

• Decompensated cirrhosis: Repeat liver function tests every 1-3 months 1
• Stable compensated cirrhosis: Laboratory monitoring every 6 months, including Child-Pugh and MELD score components 1

Common Pitfalls to Avoid

• Do not rely on a single test—no individual laboratory test is sufficient to assess all liver functions 6, 7
• The overall clinical impression is less informative than specific laboratory findings or validated scoring systems 2
• Normal transaminases do not exclude cirrhosis; synthetic function markers (albumin, INR) and platelet count are more reliable 1, 2
• If any of these four variables are present, cirrhosis can be predicted with 90% specificity: platelet count <100,000/μL, albumin <3.5 g/dL, INR >1.3, or surface nodularity on imaging 4